Is NRx Pharmaceuticals Stock a Good Investment?
NRx Pharmaceuticals Investment Advice | NRXPW |
- Examine NRx Pharmaceuticals' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research NRx Pharmaceuticals' leadership team and their track record. Good management can help NRx Pharmaceuticals navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceutical Products space and any emerging trends that could impact NRx Pharmaceuticals' business and its evolving consumer preferences.
- Compare NRx Pharmaceuticals' performance and market position to its competitors. Analyze how NRx Pharmaceuticals is positioned in terms of product offerings, innovation, and market share.
- Check if NRx Pharmaceuticals pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about NRx Pharmaceuticals' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in NRx Pharmaceuticals stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if NRx Pharmaceuticals is a good investment.
Sell | Buy |
Strong Sell
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine NRx Pharmaceuticals Stock
Researching NRx Pharmaceuticals' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company recorded a loss per share of 6.25. NRx Pharmaceuticals had not issued any dividends in recent years.
To determine if NRx Pharmaceuticals is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding NRx Pharmaceuticals' research are outlined below:
| NRx Pharmaceuticals is way too risky over 90 days horizon | |
| NRx Pharmaceuticals has some characteristics of a very speculative penny stock | |
| NRx Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| NRx Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (30.15 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NRx Pharmaceuticals has accumulated about 24.55 M in cash with (21.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
NRx Pharmaceuticals' market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 714.61 M.Basic technical analysis of NRx Stock
As of the 27th of November, NRx Pharmaceuticals secures the Risk Adjusted Performance of 0.1024, mean deviation of 38.36, and Downside Deviation of 29.41. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NRx Pharmaceuticals, as well as the relationship between them. Please verify NRx Pharmaceuticals standard deviation, as well as the relationship between the value at risk and kurtosis to decide if NRx Pharmaceuticals is priced some-what accurately, providing market reflects its recent price of 0.0529 per share. As NRx Pharmaceuticals appears to be a penny stock we also strongly suggest to check its total risk alpha numbers.NRx Pharmaceuticals' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific NRx Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on NRx Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases NRx Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Javitt Daniel C. over six months ago Disposition of 33018 shares by Javitt Daniel C. of NRx Pharmaceuticals at 1.0523 subject to Rule 16b-3 | ||
Kim Bennett over six months ago Insider Trading |
Understand NRx Pharmaceuticals' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing NRx Pharmaceuticals' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1024 | |||
| Market Risk Adjusted Performance | 0.5211 | |||
| Mean Deviation | 38.36 | |||
| Semi Deviation | 18.48 | |||
| Downside Deviation | 29.41 | |||
| Coefficient Of Variation | 826.58 | |||
| Standard Deviation | 137.75 | |||
| Variance | 18974.2 | |||
| Information Ratio | 0.12 | |||
| Jensen Alpha | 12.73 | |||
| Total Risk Alpha | (5.04) | |||
| Sortino Ratio | 0.5622 | |||
| Treynor Ratio | 0.5111 | |||
| Maximum Drawdown | 1029.69 | |||
| Value At Risk | (29.69) | |||
| Potential Upside | 30.0 | |||
| Downside Variance | 864.97 | |||
| Semi Variance | 341.54 | |||
| Expected Short fall | (46.88) | |||
| Skewness | 7.11 | |||
| Kurtosis | 51.71 |
| Risk Adjusted Performance | 0.1024 | |||
| Market Risk Adjusted Performance | 0.5211 | |||
| Mean Deviation | 38.36 | |||
| Semi Deviation | 18.48 | |||
| Downside Deviation | 29.41 | |||
| Coefficient Of Variation | 826.58 | |||
| Standard Deviation | 137.75 | |||
| Variance | 18974.2 | |||
| Information Ratio | 0.12 | |||
| Jensen Alpha | 12.73 | |||
| Total Risk Alpha | (5.04) | |||
| Sortino Ratio | 0.5622 | |||
| Treynor Ratio | 0.5111 | |||
| Maximum Drawdown | 1029.69 | |||
| Value At Risk | (29.69) | |||
| Potential Upside | 30.0 | |||
| Downside Variance | 864.97 | |||
| Semi Variance | 341.54 | |||
| Expected Short fall | (46.88) | |||
| Skewness | 7.11 | |||
| Kurtosis | 51.71 |
Consider NRx Pharmaceuticals' intraday indicators
NRx Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of NRx Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.0227 | |||
| Daily Balance Of Power | 1.583333 | |||
| Rate Of Daily Change | 1.04 | |||
| Day Median Price | 0.0523 | |||
| Day Typical Price | 0.0525 | |||
| Market Facilitation Index | 0.0012 | |||
| Price Action Indicator | 0.0016 | |||
| Period Momentum Indicator | 0.0019 | |||
| Relative Strength Index | 48.19 |
NRx Stock media impact
Far too much social signal, news, headlines, and media speculation about NRx Pharmaceuticals that are available to investors today. That information is available publicly through NRx media outlets and privately through word of mouth or via NRx internal channels. However, regardless of the origin, that massive amount of NRx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of NRx Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of NRx Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to NRx Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive NRx Pharmaceuticals alpha.
NRx Pharmaceuticals Corporate Management
| Suzanne Messere | Investor Relations | Profile | |
| Robert MIM | Chief Operations | Profile | |
| Michael Kunz | Gen Sec | Profile | |
| Molly Cogan | Sr Affairs | Profile | |
| Seth Voorhees | CFO Treasurer | Profile |
Additional Tools for NRx Stock Analysis
When running NRx Pharmaceuticals' price analysis, check to measure NRx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRx Pharmaceuticals is operating at the current time. Most of NRx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRx Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.